Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 501–600 of 1,000
CHEN, F., Sun, Z., Ye, L., Fu, G., Mou, Y., & Hu, S. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2771 · Cited by 27
“In clinical patients, lysosome-associated membrane protein 2 deficiency, a critical fusion factor between autophagosomes and lysosomes, results in a lethal cardiac hypertrophy (24).”
Age-related decrease of the LAMP-2 gene expression in human leukocytes
Huang, J. A., Xu, J., Pang, S., Bai, B., & Yan, B. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.06.016 · Cited by 28
“Mutations in LAMP-2 gene cause Danon disease, an X-linked dominant disorder characterized with hypertrophic cardiomyopathy, skeletal myopathy, and mental retardation [27].”
BackgroundKnockdown of cathepsin D in zebrafish fertilized eggs determines congenital myopathy
Follo, C., Ozzano, M., Montalenti, C., Santoro, M. M., & Isidoro, C. (2013) · Bioscience Reports · doi:10.1042/bsr20120100 · Cited by 27
Charcot–Marie–Tooth features and maculopathy in a patient with Danon disease
Laforêt, P., Charron, P., Maisonobe, T., Romero, N. B., Villard, E., Sébillon, P., Drouin‐Garraud, V., Dubourg, O., Fardeau, M., Komajda, M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000141858.80738.aa · Cited by 27
Bornemann, A., & Goebel, H. H. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00393.x · Cited by 27
Lysosomal glucose sensing and glycophagy in metabolism
Mancini, M. C., Noland, R. C., Collier, J. J., Burke, S. J., Stadler, K., & Heden, T. D. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.07.008 · Cited by 26
Lysosome-Targeting Strategy Using Polypeptides and Chimeric Molecules
Mondal, B., Dutta, T., Padhy, A., Das, S., & Gupta, S. S. (2021) · ACS Omega · doi:10.1021/acsomega.1c04771 · Cited by 26
Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?
Lodato, V., Parlapiano, G., Calì, F., Silvetti, M. S., Adorisio, R., Armando, M., Hachem, M. E., Romanzo, A., Dionisi‐Vici, C., Digilio, M. C., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9020047 · Cited by 26
“DD is apparently rare, but its geographic distribution is wide [108,109].”
BackgroundZhong, Y., Tang, K., Nattel, S., Zhai, M., Gong, S., Yu, Q., Zeng, Y., Guangxi, E., Maimaitiaili, N., Wang, J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102606 · Cited by 26
Autophagy Intertwines with Different Diseases—Recent Strategies for Therapeutic Approaches
Ramesh, J., Ronsard, L., Gao, A., & Venugopal, B. (2019) · Diseases · doi:10.3390/diseases7010015 · Cited by 26
Danon disease: Case report and detection of new mutation
Regelsberger, G., Höftberger, R., Pickl, W. F., Zlabinger, G. J., Körmöczi, U., Salzer‐Muhar, U. E., Luckner, D., Bodamer, O. A., Mayr, J. A., Muss, W. H., et al. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1097-9 · Cited by 26
LAMP-2 Positive Vacuolar Myopathy with Dilated Cardiomyopathy
Sugimoto, S., Shiomi, K., Yamamoto, A., Nishino, I., Nonaka, I., & Ohi, T. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6265 · Cited by 26
“Nowadays, it is found that Danon disease is not a glycogen storage disease because glycogen is not always increased and because the primary defect resides in LAMP-2, a lysosomal structural protein rather than a glycolytic enzyme (5, 6).”
BackgroundSelf-citationGiuffrè, B. L., Parini, R., Rizzuti, T., Morandi, L. O., van Diggelen, O. P., Bruno, C., Giuffrè, M., Corsello, G., & Mosca, F. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000042980.45692.bb · Cited by 26
“Danon disease is an X-linked progressive cardiomyopathy and myopathy characterized by intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells (Danon et al 1981; Nishino et al 2000).”
BackgroundDOUBLE-BLIND, PLACEBO-CONTROLLED, PILOT TRIAL OF BOTULINUM TOXIN A IN RESTLESS LEGS SYNDROME
Nahab, F. B., Peckham, E. L., & Hallett, M. (2008) · Neurology · doi:10.1212/01.wnl.0000325994.93782.a1 · Cited by 26
“The maximum dose was 90 mU per leg, distributed in the following sites (number of injections): QF- 40mU (4); TA-20mU (2); GCS-20mU (2); SOL-10mU (1).”
BackgroundSterile Inflammation and Degradation Systems in Heart Failure
Nishida, K., & Otsu, K. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0261 · Cited by 27
Autophagic vacuolar pathology in desminopathies
Weihl, C. C., Iyadurai, S. J. P., Baloh, R. H., Pittman, S. K., Schmidt, R. E., Lopate, G., Pestronk, A., & Harms, M. B. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.12.002 · Cited by 25
“Several genes have been identified as causing an AVM with AVSF myopathology and include LAMP2, VMA21, and more recently CLN3 [3–5].”
BackgroundLiu, Y., Wang, F., Chen, X., Liang, Y., Deng, H., Liao, H., Rao, F., Wei, W., Zhang, Q., Zhang, B., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006704 · Cited by 25
Liu, Y., Chen, X., Wang, F., Liang, Y., Deng, H., Liao, H., Zhang, Q., Zhang, B., Zhan, X., Fang, X., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.638 · Cited by 25
“…by the mutations in the gene of lysosome‐ associated membrane protein 2 (LAMP2,OMIM*309060), is an X‐linked dominant disorder classically characterized by the triad of cardiomyopathy, skeletal myopathy, and intellectual disability (Danon et al., 1981; Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundRahmani, Z., Surabhi, S., Rojo-Cortés, F., Dulac, A., Jenny, A., & Birman, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113078 · Cited by 25
“This is reinforced by the fact that mutations in the LAMP2 gene cause Danon disease, a rare lysosomal disorder affecting infants, histologically characterized by an accumulation of vacuoles in skeletal and cardiac muscle tissues [10] and an impaired fusion between the lysosomes and the autophagosomes [11,12].”
BackgroundLee, E., Park, K.-S., Jeon, I.-S., Choi, J., Lee, S.-J., Choy, H. E., Song, K., Lee, H.-K., & Choi, J.-K. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0112 · Cited by 25
“Moreover, LAMP-2 deficiency is associated with Danon disease, a lysosomal storage disease, characterized by vacuolar cardiomyopathy and myopathy (Nishino et al., 2000).”
BackgroundAbnormal lysosomal and ubiquitin‐proteasome pathways in 19p13.3 distal myopathy
Blasi, C. D., Moghadaszadeh, B., Ciano, C., Negri, T., Giavazzi, A., Cornelio, F., Morandi, L. O., & Mora, M. (2004) · Annals of Neurology · doi:10.1002/ana.20158 · Cited by 25
“Thus, the vacuole characteristics in our family suggest protein degradation abnormalities, as in DD.(18) Muscle contains at least three protein degradation systems: lysosomal proteases, nonlysosomal intracellular Ca -dependent proteases, and nonlysosomal ATPubiquitin–dependent proteases.”
BackgroundSelf-citationFabry disease cardiomyopathy: A state-of-the-art review
Pande, S., Varzideh, F., Gambardella, J., Jankauskas, S. S., Cerasuolo, F. A., Spinelli, L., Kansakar, U., Luca, A. D., Kurland, I. J., Sidoli, S., et al. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.08.003 · Cited by 24
Ferrari, E., Breda, D., Longhi, R., Vangelista, L., Nakaie, C. R., Elviri, L., Casali, E., Pertinhez, T. A., Spisni, A., & Burastero, S. E. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000327551 · Cited by 24
Relationships Between Disc Degeneration and Autophagy Expression in Human Nucleus Pulposus
Quan, M., Hong, M. W., Ko, M., & Kim, Y. (2019) · Orthopaedic Surgery · doi:10.1111/os.12573 · Cited by 24
Genetic defects of autophagy linked to disease
Fraiberg, M., & Elazar, Z. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.001 · Cited by 24
Terasawa, K., Kato, Y., Ikami, Y., Sakamoto, K., Ohtake, K., Kusano, S., Tomabechi, Y., Kukimoto‐Niino, M., Shirouzu, M., Guan, J., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1911017 · Cited by 24
“LAMP2B is highly expressed in human cardiomyocytes, where its deficiency impairs the autophagosome-lysosome fusion to cause the cardiomyopathy in Danon disease [11,12].”
BackgroundDanon disease with typical early‐onset cardiomyopathy in a male: Focus on a novel LAMP‐2 mutation
Bui, Y. K., Renella, P., Martínez-Agosto, J. A., Verity, A., Madikians, A., & Alejos, J. C. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00874.x · Cited by 24
“(24) were the first to identify mutations in the LAMP-2 gene as the cause of Danon disease.”
BackgroundHeterogeneity in a large pedigree with Danon disease: Implications for pathogenesis and management
Roos, J. C. P., Daniels, M. J., Morris, E., Hyry, H. I., & Cox, T. M. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.06.008 · Cited by 24
Chapter 19 Monitoring Autophagy in Muscle Diseases
Malicdan, M. C. V., Noguchi, S., & Nishino, I. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04019-6 · Cited by 24
Self-citationCD47 Deficiency Attenuates Isoproterenol-Induced Cardiac Remodeling in Mice
Zuo, Z., Ji, M., Zhao, K., Su, Z., Li, P., Hou, D., & Li, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7121763 · Cited by 23
“LAMP2 knockdown impairs autophagy in adult rat ventricular myocytes and causes cell death at levels comparable to those associated with inhibition of autophagy [103], ablation of LAMP2 [89], or loss of LAMP2 [104] protein due to mutations in individuals with Danon disease [105], which is characterized by autophagosome…”
BackgroundDanon disease for the cardiologist: case report and review of the literature
D'Souza, R. S., Mestroni, L., & Taylor, M. R. G. (2017) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2017.1324239 · Cited by 23
“Muscle biopsy will show normal acid maltase levels [1], immunohistochemistry will show LAMP2 protein deficiency [2], and genetic mutation analysis will reveal a LAMP2 truncation mutation [15].”
BackgroundAtmospheric PM2.5 blocking up autophagic flux in HUVECs via inhibiting Sntaxin-17 and LAMP2
Liu, Y., Zhao, D., Peng, W., Xue, P., Jiang, X., Chen, S., Gao, H., Wang, X., & Feng, S. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111450 · Cited by 23
Autophagy in Acute Pancreatitis: Organelle Interaction and microRNA Regulation
Yuan, X., Wu, J., Guo, X., Li, W., Luo, C., Li, S., Wang, B., Tang, L., & Sun, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8811935 · Cited by 23
“In recent years, autophagy has been confirmed to play an important role in the progression of many diseases, such as neurodegenerative diseases [13, 14], cardiomyopathy [15, 16], fatty liver [17] and cancers [18].”
BackgroundThe Glycogen Storage Diseases and Related Disorders
Walter, J. H., Labrune, P., & Laforêt, P. (2016) · Springer eBooks · doi:10.1007/978-3-662-49771-5_5 · Cited by 23
Säftig, P. (2006) · Cited by 23
A 13‐year‐old girl with proximal weakness and hypertrophic cardiomyopathy with danon disease
Kim, H., Cho, A., Lim, B. C., Kim, M. J., Kim, K. J., Nishino, I., Hwang, Y. S., & Chae, J. (2010) · Muscle & Nerve · doi:10.1002/mus.21614 · Cited by 23
Self-citationMoreno, R. D. (2003) · Molecular Reproduction and Development · doi:10.1002/mrd.10342 · Cited by 24
“On the other hand, in the absence of LAMP-2 mice die very early and they manifest a vacuolar cardioskeletal myopathy similar to Danon disease, pointing to this protein as a major cause of the disease in humans (Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundClearing the Brains Cobwebs: The Role of Autophagy in Neuroprotection
Bossy, B., Perkins, G. A., & Bossy‐Wetzel, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908784533897 · Cited by 23
“In the final portion of this review, we discuss the therapeutic promise of inducing autophagy and the potential side effects of such treatments.”
Yoshida, S., Nakanishi, C., Okada, H., Mori, M., Yokawa, J., Yoshimuta, T., Ohta, K., Konno, T., Fujino, N., Kawashiri, M., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.11.019 · Cited by 22
Nora, C. D., Miani, D., D'Elia, A. V., Poli, S., Iascone, M. R., Nucifora, G., Finato, N., Sponga, S., Proclemer, A., & Livi, U. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.04.002 · Cited by 22
Chaperone-Mediated Autophagy after Spinal Cord Injury
Handa, K., Kanno, H., Matsuda, M., Sugaya, T., Murakami, T., Prudnikova, M., Ozawa, H., & Itoi, E. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6820 · Cited by 22
“18,19 Numerous studies have shown that an altered CMA activity is associated with different pathologies in various human diseases affecting the central nervous system (CNS).”
Bai, F., Wu, Q.-Q., Wu, Y., Hu, Y., Jiang, Z.-X., Lv, H., Qian, W.-Z., Cai, C., & Wu, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05116-w · Cited by 22
“LAMP2B might be related to macroautophagy and affect the maturation of autophagosomes [33].”
Lysosomal storage and advanced senescence in the brain of LAMP-2-deficient Danon disease
Furuta, A., Wakabayashi, K., Haratake, J., Kikuchi, H., Kabuta, T., Mori, F., Tokonami, F., Katsumi, Y., Tanioka, F., Uchiyama, Y., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1075-4 · Cited by 22
Self-citationCardioembolic stroke in Danon disease
Spinazzi, M., Fanin, M., Melacini, P., Nascimbeni, A. C., & Angelini, C. I. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.00971.x · Cited by 22
“To the Editor: Danon disease is a rare X-linked dominant disorder caused by lysosome-associated membrane protein 2 (LAMP2) gene mutations (1), characterized by prominent hypertrophic cardiomyopathy (HCM), myopathy, mental retardation, Wolff–Parkinson–White syndrome (WPW), hepatopathy, and retinopathy (1–5).”
BackgroundNarrowing in on the causative defect of an intriguing X-linked myopathy with excessive autophagy
Minassian, B. A., Aiyar, R. S., Alic, S., Banwell, B., Villanova, M., Fardeau, M., Mandell, J. W., Juel, V. C., Rafii, M. S., Auranen, M., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.596 · Cited by 22
VMP1-deficient Chlamydomonas exhibits severely aberrant cell morphology and disrupted cytokinesis
Tenenboim, H., Smirnova, J., Willmitzer, L., Steup, M., & Brotman, Y. (2014) · BMC Plant Biology · doi:10.1186/1471-2229-14-121 · Cited by 22
“The accumulation of starch, as seen in our TEM images, may also be a sign of disrupted autophagy: the aberrant accumulation of glycogen, starch's animal counterpart, in three genetic human diseases—Lafora disease [37], Pompe disease [38], and Danon disease [39]—with detrimental pathophysiologies, has been shown in the…”
BackgroundThe Molecular Mechanism and Therapeutic Application of Autophagy for Urological Disease
Chueh, K., Lu, J., Juan, T.-J., Chuang, S., & Juan, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914887 · Cited by 21
Linee guida ESC 2023 per il trattamento delle cardiomiopatie
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Villa, R. B., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · Giornale Ialiano di Cardiologia · doi:10.1714/4127.41209 · Cited by 22
Favero, G. D., Bonifacio, A., Rowland, T. J., Gao, S., Song, K., Sergo, V., ADLER, E. D., Mestroni, L., Sbaizero, O., & Taylor, M. R. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082457 · Cited by 21
“Danon disease is a rare, severe X-linked disorder caused by deficiency of lysosome-associated membrane protein-2 (LAMP-2) and characterized by skeletal and cardiac myopathy, retinopathy, and intellectual disability [1].”
BackgroundDanon disease: A novel Lamp-2 gene mutation in a family with four affected members
Tuñón, T., Guerrero, D., Urchaga, A., Nishino, I., Ayuso, T., Matsuda, Y., Caballero, M., Reyero, J. B., & Imizcoz, M. A. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.09.008 · Cited by 21
Self-citationFuruta, A., Kikuchi, H., Fujita, H., Yamada, D., Fujiwara, Y., Kabuta, T., Nishino, I., Wada, K., & Uchiyama, Y. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.015 · Cited by 21
Self-citationiPS Cell Modeling of Cardiometabolic Diseases
Nakamura, K., Hirano, K., & Wu, S. M. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9413-4 · Cited by 20
Skeletal muscle-specific Sidt2 knockout in mice induced muscular dystrophy-like phenotype
Liu, H., Jiang, W., Chen, X., Chang, G., Zhao, L., Li, X., & Zhang, H. (2018) · Metabolism · doi:10.1016/j.metabol.2018.05.004 · Cited by 20
Clinical features and cardiovascular magnetic resonance characteristics in Danon disease
He, J., Xu, J., Chen, L., Ji, K., Fan, X., Zhao, S., & Lu, M. (2020) · Clinical Radiology · doi:10.1016/j.crad.2020.04.012 · Cited by 20
Majer, F., Pelák, O., Kalina, T., Vlášková, H., Dvořáková, L., Honzík, T., Paleček, T., Kuchynka, P., Masek, M., Zeman, J., et al. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9617-z · Cited by 20
“DD is caused by mutations in the lysosomalassociated membrane protein 2 (LAMP2) gene (Xq24) (Nishino et al 2000), which codes a single pass transmembrane protein that functions as a critical regulator of autophagosomal/phagosomal processing within the late endosomal/lysosomal system (Eskelinen…”
BackgroundBlasi, C. D., Jarre, L., Blàsevich, F., Dassi, P., & Mora, M. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.09.008 · Cited by 20
“Mutations in the LAMP2 gene encoding the lysosomal-associated membrane protein 2 (LAMP-2; Online Mendelian Inheritance in Man database 309060) have been shown to be responsible for the primary defect in Danon disease [4].”
BackgroundSelf-citationLópez‐Sainz, Á., Salazar‐Mendiguchía, J., García-Álvarez, M. I., Campuzano, Ó., López-Garrido, M. Á., García-Guereta, L., Cañamero, M. E. F., Climent, V. E., Peña‐Peña, M. L., Zorio, E., et al. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.04.027 · Cited by 20
Danon disease: Further clinical and molecular heterogeneity
Sabourdy, F., Michelakakis, H., Anastasakis, A., Garcia, V., Mavridou, I., Niéto, M., Pons, M., Skiadas, C., Moraitou, M., Manta, P., et al. (2009) · Muscle & Nerve · doi:10.1002/mus.21252 · Cited by 20
“individually amplified using Ampli-Taq Gold DNA polymerase (Applied Biosystems, Foster City, California), under the conditions reported by Nishino et al.(24) Exons 5–7 of the GLA gene were amplified using Platinum Taq DNA polymerase (Invitrogen) and previously described primers.”
BackgroundMethodInfluentialDanon Disease: An Unusual Presentation of Autism
Burusnukul, P., Reyes, E. D. L., Yinger, J., & Boué, D. R. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.03.011 · Cited by 20
Chaperone-mediated autophagy as a modulator of aging and longevity
Endicott, S. J. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1509400 · Cited by 19
Zaki, A. O., Zaidi, A. M., Newman, W. G., & Garratt, C. J. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12142 · Cited by 19
In situ measurement of autophagy under nutrient starvation based on interfacial pH sensing
Sakata, T., Saito, A., & Sugimoto, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26719-4 · Cited by 19
Melanoma LAMP-2C Modulates Tumor Growth and Autophagy
Pérez, L., Sinn, A. L., Sandusky, G. E., Pollok, K. E., & Blum, J. S. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00101 · Cited by 19
Models to study basic and applied aspects of lysosomal storage disorders
Gaudioso, Á., Silva, T. P., & Ledesma, M. D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114532 · Cited by 19
Byrne, S., Dlamini, N., Lumsden, D. E., Pitt, M. C., Zaharieva, I. T., Muntoni, F., King, A., Robert, L., & Jungbluth, H. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.04.003 · Cited by 19
“MSS, VS [15] and CHS [16] also share a skeletal muscle myopathy with prominent vacuoles, the hallmark of myopathies due to primary autophagy defects [17,18], further indicating a communality of muscle and nerve involvement in disorders with abnormalities of the lysosomal–autophagic pathway.”
BackgroundStorage diseases with hypertrophic cardiomyopathy phenotype
Ruiz‐Guerrero, L., & Villa, R. B. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.28 · Cited by 19
Montalvo, R. N., Doerr, V., Kwon, O. S., Talbert, E. E., Yoo, J., Hwang, M., Nguyen, B. L., Christou, D. D., Kavazis, A. N., & Smuder, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218105 · Cited by 19
“deficiency of lysosome-associated membrane protein 2 (LAMP2), a protein required for formation of the autolysosome, resulted in accumulation of autophagic vacuoles, impaired protein degradation and the development of cardiomyopathy [22,23].”
BackgroundAutophagy in Myocardial Differentiation and Cardiac Development
Simon, H. (2012) · Circulation Research · doi:10.1161/circresaha.112.265157 · Cited by 19
Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases
Uribe-Carretero, E., Rey, V., Fuentes, J. M., & Tamargo‐Gómez, I. (2024) · Biology · doi:10.3390/biology13010034 · Cited by 18
Darden, D. J., Hsu, J. C., Tzou, W. S., von Alvensleben, J. C., Brooks, M., Hoffmayer, K. S., Brambatti, M., Sauer, W. H., Feld, G. K., & ADLER, E. D. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.03.024 · Cited by 18
Autophagy guided interventions to modify the cardiac phenotype of Danon disease
Yadin, D., Petrover, Z., Shainberg, A., Alcalai, R., Waldman, M., Seidman, J. G., Seidman, C. E., Abraham, N. G., Hochhauser, E., & Arad, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115229 · Cited by 18
Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a boy with Danon disease.
Fidziańska, A., Walczak, E., & Walski, M. (2007) · PubMed · Cited by 18
Autophagy facilitates secretion and protects against degeneration of the Harderian gland
Koenig, U., Fobker, M., Lengauer, B., Brandstetter, M., Resch, G. P., Gröger, M., Plenz, G. A. M., Pammer, J., Barresi, C., Hartmann, C., et al. (2014) · Autophagy · doi:10.4161/15548627.2014.978221 · Cited by 18
“Any impairment of clearance causes the formation of vacuoles and aggregates.(7) The aggresome is a specialized structure, accumulating ubiquitinated and misfolded proteins, particularly in amyloid diseases.”
BackgroundHashida, Y., Wada, T., Saito, T., Ohta, K., Kasahara, Y., & Yachie, A. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.09.011 · Cited by 18
“reported that mutations in LAMP2, which resides on chromosome Xq24 and encodes the lysosome-associated membrane protein-2 (LAMP-2), are responsible for the primary defect in Danon disease [2].”
BackgroundMethodElectron Microscopy in Neuromuscular Disorders
Fernandez, C., Figarella‐Branger, D., Meyronet, D., Cassote, E., Tong, S., & Pellissier, J. (2005) · Ultrastructural Pathology · doi:10.1080/01913120500323175 · Cited by 18
“LAMP2 (lysosomal associated membrane protein 2, located at Xq24) deficiency is also referred to as Danon disease, lysosomal storage disease with normal acid maltase, and X-linked vacuolar cardiomyopathy and mental retardation [12].”
BackgroundCerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal Aging
Loeffler, D. A., Klaver, A. C., Coffey, M. P., & Aasly, J. O. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00130 · Cited by 19
“…(HSPA8) complex is rate-limiting for CMA (Cuervo and Dice, 1996), lamp2b is involved in macroautophagy (and may be required for autophagosome-lysosome fusion; Nishino et al., 2000; Rowland et al., 2016), and lamp2c is a receptor for autophagic degradation of DNA and RNA (Fujiwara et al., 2015).”
BackgroundAmato, A. A., & Dumitru, D. (2002) · Elsevier eBooks · doi:10.1016/b978-1-56053-433-4.50035-3 · Cited by 18
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4
Orth, M., & Mundegar, R. R. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00186-4 · Cited by 18
Roles of Autophagy and Oxidative Stress in Cardiovascular Disease
Yun, H. R., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Kim, S. S., & Kang, I. (2025) · Antioxidants · doi:10.3390/antiox14101263 · Cited by 18
“Danon disease (glycogen storage disease Type IIB) with LAMP2 deficiency produces severe hypertrophic or dilated phenotypes with lysosomal dysfunction [208–210].”
Protein homeostasis in the aged and diseased heart
Mainali, N., Ayyadevara, S., Ganne, A., Reis, R. J. S., & Mehta, J. L. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.4 · Cited by 17
Autophagy in the stress-induced myocardium
McCormick, J. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/530 · Cited by 17
“Gene sequencing data from a cohort of 11 probands with Danon’s disease revealed, in all but one proband, mutations in the lamp-2 gene (53).”
BackgroundInfluentialElectrophysiological findings in X‐linked myopathy with excessive autophagy
Jääskeläinen, S. K., Juel, V. C., Udd, B., Villanova, M., Liguori, R., Minassian, B. A., Falck, B., Niemi, P., & Kalimo, H. (2002) · Annals of Neurology · doi:10.1002/ana.10173 · Cited by 17
Pereira, E. M., do Monte, S. J. H., do Nascimento, F. F., de Castro, J. A. F., de Sousa, J. L. M., Filho, H. C. S. D. A. L. C., da Silva, R. N., Labilloy, A., Neto, J. T. M., & da Silva, A. S. (2013) · Gene · doi:10.1016/j.gene.2013.11.063 · Cited by 17
Rare Forms of Preexcitation: A Case Study and Brief Overview of Familial Forms of Preexcitation
Koneru, J. N., Wood, M. A., & Ellenbogen, K. A. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.968917 · Cited by 17
Son, S. Y., Lee, H., & Kim, S. J. (2017) · Micro and Nano Systems Letters · doi:10.1186/s40486-017-0042-1 · Cited by 17
“cancer marker [11] and lysosome-associated membrane protein 2 (lamp-2, 185 bp) encoding gene as Danon disease marker [12]) was injected and they were selectively preconcentrated at different locations having the amplification ratio of 20 and 60, respectively.”
Gourzi, P., Pantou, M. P., Gkouziouta, A., Kaklamanis, L., Tsiapras, D. P., Zygouri, C., Constantoulakis, P., Adamopoulos, S. N., & Degiannis, D. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.05.015 · Cited by 17
“The onset of the disease during adolescence is followed by a rapid progression toward end-stage heart failure in adulthood, often resulting in death (Arad et al., 2005; Nishino et al., 2000).”
BackgroundGurka, J., Piherová, L., Majer, F., Chaloupka, A., Žáková, D., Pelák, O., Krebsová, A., Peichl, P., Krejčí, J., Freiberger, T., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12823 · Cited by 17
“Danon disease (DD, OMIM 300257) is a rare X-linked disorder caused by mutations in the lysosomal-associated membrane protein type 2 gene (LAMP2, Xq24).(1) All three LAMP2 isoforms (B, A, and C) contribute to lysosomal processing of autophagic substrates.”
BackgroundCD47 antibody suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy.
Li, Y., Chen, X., Li, P., Xiao, Q., Hou, D., & Kong, X. (2020) · PubMed Central · Cited by 17
Säftig, P. (2007) · Springer eBooks · doi:10.1007/0-387-28957-7_4 · Cited by 17
Liu, Y., Zhao, Y., Qin, Y., Du, X., Wang, Q., & Lyu, J. (2016) · RSC Advances · doi:10.1039/c5ra26225a · Cited by 17
Chen, X., Zhao, Y. M., Ke, H., Liu, W., Du, Z., & Zhang, X. (2012) · Gene · doi:10.1016/j.gene.2012.06.064 · Cited by 16
No cardiomyopathy in X-linked myopathy with excessive autophagy
Saraste, A., Koskenvuo, J. W., Airaksinen, J. K. E., Ramachandran, N., Munteanu, I., Udd, B., Huovinen, S., Kalimo, H., & Minassian, B. A. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.03.003 · Cited by 16
“In Danon disease the mutations in LAMP2 gene, encoding lysosomal-associated membrane protein-2, result in accumulation of autophagic vacuoles in cardiomyocytes and progressive severe cardiac dysfunction, often necessitating cardiac transplantation [4,5].”
BackgroundAutophagic vacuolar myopathy in twin girls
Holton, J. L., Beesley, C. E., Jackson, M., Venner, K., Bhardwaj, N., WINCHESTER, B. G., & Al‐Memar, A. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00691.x · Cited by 16
The dual effects of autophagy in myocardial hypertrophy
Li, J., & Cai, Y. (2015) · Acta cardiologica. Supplementum · doi:10.1080/ac.70.4.3096899 · Cited by 16
Danon disease: intrafamilial phenotypic variability related to a novel LAMP‐2 mutation
Cottinet, S., Bergemer-Fouquet, A.-M., Toutain, A., Sabourdy, F., Maakaroun-Vermesse, Z., Levade, T., Chantepie, A., & Labarthe, F. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9251-y · Cited by 16
“Finally, Danon disease was confirmed by molecular analysis, demonstrating a novel mutation in the LAMP-2 gene (Fanin et al. 2006; Nishino et al. 2000).”
BackgroundMethodInfluentialSukumaran, V., Gurusamy, N., Yalcin, H. C., & Venkatesh, S. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02651-x · Cited by 15
Critical role of Znhit1 for postnatal heart function and vacuolar cardiomyopathy
Shi, Y., Fan, W., Xu, M., Lin, X., Zhao, W., & Yang, Z. (2022) · JCI Insight · doi:10.1172/jci.insight.148752 · Cited by 15
“It is usually associated with lysosomal functional deficiencies, including storage disorders (namely, Pompe disease, resulting from acid α -glucosidase deficiency) and protein deficiency (namely, Danon disease, resulting from LAMP2 deficiency) (8–10).”
Loss of chaperone-mediated autophagy is associated with low vertebral cancellous bone mass
Akel, N. S., MacLeod, R. S., Berryhill, S. B., Laster, D. J., Dimori, M., Crawford, J. A., Fu, Q., & Onal, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-07157-9 · Cited by 15
Glycogen Storage Diseases of Muscle
Akman, H. O., Oldfors, A., & DiMauro, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00039-1 · Cited by 15
Self-citationGenetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians
Care, M. E., Chauhan, V. S., & SPEARS, D. A. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0885-3 · Cited by 15
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.